JCO oncology practice
Risk of Colitis in Patients With Inflammatory Bowel Disease or Microscopic Colitis Exposed to Checkpoint Inhibitors: A National Danish Cohort Study.
Emilie Kristine Dahl, Katrine Risager Christensen, Henrik Albæk Jacobsen, Anders Kverneland, Anders Dige, Inge Marie Svane, Marco Donia, Jacob Tveiten Bjerrum, Jakob Benedict Seidelin
Published: 202510.1200/OP-25-00390
Abstract
PURPOSE: Patients with intestinal inflammatory diseases such as ulcerative colitis (UC), Crohn's disease (CD), and microscopic colitis (MC) are excluded from clinical trials with immune checkpoint inhibitors (ICI) because of concerns of exacerbating…
Preview only. Read the full abstract at the source